chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen; In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen; In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen), VACCINATION SITE ERYTHEMA (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen) and VACCINATION SITE SWELLING (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Prediabetes.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen), VACCINATION SITE ERYTHEMA (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen) and VACCINATION SITE SWELLING (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen). At the time of the report, VACCINATION SITE PRURITUS (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen), VACCINATION SITE ERYTHEMA (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen) and VACCINATION SITE SWELLING (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included medication for hypertension and prediabetes.  No treatment information was provided.
moderate body aches; severe diarhhea; severe lower back pain; patient received third dose of BNT162B2; patient received third dose of BNT162B2; This is a spontaneous report from a contactable other healthcare professional. A 60-year-old male patient received the third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscularly in the left arm, on 11Oct2021 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunization. Medical history included hypertension. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included influenza vaccine (FLU) taken for immunisation; ibuprofen (ADVIL); probiotics (MANUFACTURER UNKNOWN); acetylsalicylic acid (ASPIRIN); and metoprolol (MANUFACTURER UNKNOWN). The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), first dose on an unspecified date at 17:00 and second dose on 11May2021 at 17:00 (at the age of 60-years-old), both intramuscularly in the left arm for COVID-19 immunization. The patient experienced moderate body aches, severe diarrhea, and severe lower back pain on 11Oct2021 19:00. The patient received third dose of BNT162B2 on 11Oct2021 12:00. Therapeutic measures were taken as a result of the events, which included treatment with ibuprofen (ADVIL). The clinical outcome of moderate body aches, severe diarrhea, and severe lower back pain was not recovered and of patient received third dose of BNT162B2 was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Patient is 12 years old . Received the Pfizer 5-11 0.2ml
suspected vaccination failure; 15 people I have spoken to who said they experienced shingles / all of them say they got it after; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  The patient received Shingles vaccine and experienced shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. This case was one of the 16 cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR088499: US-GLAXOSMITHKLINE-US2021AMR088498:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088476:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088496:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088503:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088504:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088507:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088497:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088501:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088502:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088506:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088495:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088494:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088505:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088531:Original Case : US2021AMR088476
Balance issues, issues walking, numbness in feet, tingling in hands, face and feet. Falling. Was diagnosed with Guillain-Barre Syndrome.
This spontaneous report as received from an office manager, refers to an approximately 5 year old patient of unknown gender. No pertinent medical history or drug reactions/allergies were provided. On an unspecified date in March 2001, when the patient was a neonate, the patient was vaccinated with the first dose of RECOMBIVAX HB (dose, route and lot number were not provided). On an unspecified date in April 2001, the patient was vaccinated with the second dose of RECOMBIVAX HB, 5 microgram (route and lot number were not provided). On an unspecified date in June 2006, the patient was vaccinated with the third dose of RECOMBIVAX HB, 5 microgram (route and lot number were not provided). On an unspecified date in March 2014, the patient was vaccinated with a fourth dose of RECOMBIVAX HB, 10 microgram (route and lot number were not provided). It was noted that the patient's weight in March 2014 was 189 pounds. No co-suspect or concomitant therapies were reported. At the time of the report, no adverse events were reported. Additional information has been requested.
muscle pain; very tired; achy; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  An 82-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 02Mar2021 (Lot number: EN6198) at the age of 82 years as dose 1, single for COVID-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: MYALGIA (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "muscle pain"; FATIGUE (non-serious) with onset Mar2021, outcome "unknown", described as "very tired"; PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "achy". Therapeutic measures were taken as a result of myalgia.  Additional information: After her 1st dose of the Pfizer COVID Vaccine, the patient had like a muscle pain and put ice on it and it went away. She also stated that she was also very tired and achy. She also mentioned that she lives in a senior community for age 55 and older.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a registered nurse concerning unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. From 14-AUG-2017 to 19-SEP-2017, the patients were vaccinated with  improperly doses of PROQUAD lot number N004631; expiration date 07-AUG-2018 or lot number N010866; expiration date 01-OCT-2018 or lot number M033209; expiration date: 09-JAN-2018 (strength, dose and route of administration were not reported) for prophylaxis. The patient's concomitant therapies included sterile diluent (MERCK STERILE DILUENT). The temperature of excursion with PROQUAD was -14 to -10 Celsius degrees. No previous temperature of excursion was performed. The temperature of excursion was detected by a data logger. No adverse effects were reported. This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-1709USA010743:
Patient's mother called in stating patient was complaining of a burning throat (as if she had swallowed hot sauce). I advised mother to go to ER if any swelling of tongue, lips, or throat occurs or if any difficulty breathing were to occur. Also, told mother to check patient's throat for signs of infection such as strep and to consult a qcare clinic or her physician if any signs of infection. Also informed patient's mother to consult the pediatrician if burning did not go away by morning and patient should increase fluid intake to help with burning sensation. Adverse event probably not associated to vaccine, but needs reported. Have not heard from patient's mother since last night for follow-up.
This spontaneous report as received from a Nurse regarding a patient of unknown demographics. There was no information about concurrent condition and historical medication. On 08-JAN-2018, the patient was vaccinated with improperly stored Oka/Merck VARIVAX lot # N022981, expiration date: 23-AUG-2019, dose 1 for prophylaxis (product storage error). Concomitant therapies included STERILE DILUENT. The vaccine had temperature excursion of -14 degree C to -10 degree C for 10 hours 15 minutes. Previous temperature excursion of -14 degree C to -10 degree C for 135 Hours and 45 Minutes. The call was due to the digital data logger. No adverse event was reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1810USA001739.
Twelve hour period of uncomfortableness; This is a spontaneous report from a contactable other hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number Unknown, Expiry Date: Unknown), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced twelve hour period of uncomfortableness. The outcome of event unknown.  Information on lot and batch number has been requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
I received my vaccine. Immediately following the shot, my left side of body went numb with electricity and pins/needles. That covered the entire left side of body from head to toe. Five days later, my arm numbness was all better but I then had cardiac issues and still do 9 months later. My heart has heart palpitations, a racing heart, dizziness, white spots upon standing, heart races when I walk, hands get blotchy just walking a short distance, SPO2 levels drop when walking, temperature regulation issues/excessive sweat like I just worked out after only walking a little bit, circulation issues to hands and feet, extreme fatigue. My doctor gave me Metoprolol to keep my heart rate down. There has not been a diagnosis yet. There has also not been a happy outcome yet as I am not healing. I need some help.
The patient was instructed to wait 15 minutes after the vaccine . after about 10 minutes , while the patient and her mother was waiting in the waiting area , the mother shouted loudly saying " she fainted " . The pharmacist went directly to the waiting area , the mother said "she's back" . The patient probably fainted for about a minute or so . When the patient gain her concious , she was sweating badly , pharmacist went and got her some gatorade . she was fine , responsive and alert , she had few sips of the drink and felt fine completly . The mother had mentioned before the vaccine the was very nervious about the vaccine and also the face that she didn't eat any thing all morning . The mother took her to the pediatrician office right after she felt fine , to check her vitals , the pediatrician suggested it could be the vaccine .
top lip suddenly began to tingle and looked puffy; top lip suddenly began to tingle and looked puffy; throat also felt like it was being squeezed on the outside; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 09:15(at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient previously took Neosporin(topical cream) on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient  receive other (unspecified) vaccines within four weeks prior to the vaccination. On 14Apr2021 at 09:50 within 35 minutes of the vaccine, while the patient was driving home the patient experienced top lip suddenly began to tingle and looked puffy and throat also felt like it was being squeezed on the outside and the patient pulled into a parking lot across from the nearest hospital emergency room to see if it was getting worse and it didn't so the patient drove 5 mins to home and then took 3 Benadryl, it was very scary. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported events and included treatment with Benadryl. The clinical outcome of the events top lip suddenly began to tingle and looked puffy and throat also felt like it was being squeezed on the outside were unknown.   No follow-up attempts are needed. No further information is expected.
Diverticulitis; This spontaneous report  was received from consumer on 18-FEB-2021, concerning a 76 year old female patient who was administered Moderna COVID-19 vaccine9( mRNA-1273). The patient experienced diverticulitis.  The patient's medical history was not provided.  Concomitant medications included was blood thinners.  The patient received suspect product  mRNA-1273 on 23 JAN 2021 prior to the onset event, the patient received their first dose of mRNA-1273 (lot number:030L20A) intramuscularly in an unknown arm for prophylaxis of COVID-19 infection.   On 4 FEB 2021, approximately within 24 hours of receiving shot, the patient experienced diverticulitis. Treatment history was not reported.  Action taken with the  dose of mRNA-1273  in response to the event was unknown.  The outcome of the event, diverticulitis was considered as unknown.; Reporter's Comments: This case concerns a 76-year-old female who experienced Serious unexpected event of Diverticulitis.  The events occurred 2 days after the first dose of mRNA-1273. Treatment not reported. Event outcome unknown.  Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
It has now been 2 months since my flu shot and I am still experiencing pain in my right deltoid area, not getting worse but not getting better.  It hurts when I abduct my arm to the horizontal position and internally or externally rotate my shoulder.  The pain wakes me up at night, makes it difficult to lift things with the affected arm, and it hurts to raise my arm above my head/put on clothing.  The pain radiates to my right clavicle.
Papular rash over the entire body, appears consistent with erythema multiforme with targetoid lesions. Specific lesions darker in the center. Mucosal involvement. Well appearing male.
diarrhea, sweating, chills, hot to touch, couldn't touch skin. 3-4 hours lasted
racing hart, severe hart palpatations,  mild hart pain, sharp head pain on both sides and a large bump and a large red circle, about 3" in diameter appeared on my arm,  seven days after I got the injection. Everything subsided seven weeks and three days after the injection.
After the second dose, patient had a lot of soreness in left arm; Achy all over for a couple of days; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (After the second dose, patient had a lot of soreness in left arm), PAIN (Achy all over for a couple of days) and FATIGUE (Very tired) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A, 024M20A and 012F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (After the second dose, patient had a lot of soreness in left arm), PAIN (Achy all over for a couple of days) and FATIGUE (Very tired). At the time of the report, PAIN IN EXTREMITY (After the second dose, patient had a lot of soreness in left arm), PAIN (Achy all over for a couple of days) and FATIGUE (Very tired) outcome was unknown.            No concomitant medications were provided.  No treatment medications were provided.   This case was linked to MOD-2021-387428 (Patient Link).
Swelling of 1/2 left upper arm. Pink and warm to touch. Tender at injection site. Reported by mother to Dr 30 hrs after injection. Advised cool compresses to affected area. Seen in office 10/19/05. Advised to continue same.
Constipation, muscle cramps, tingling in legs, numbness in legs and feet. Burning in my feet, paralyzed, can hardly walk. Autoimmune system crashed. With this I all of sudden have diabetes! No one in my family has diabetes! I am a healthy person.
Patient stated that her throat began to swell up, had a raspy voice and right sided throat soreness about 1.5 hours after administration. She stated he right arm blood vessels became very prominent as well as right arm edema and redness. For these symptoms the patient took 50mg PO of Benedryl and 4 hours later another 50mg. The following day 10/23/17 (appointment date at doctors office)  she only has right sided arm pain, accompanied with edema as well as pain to right breast.
Full body hives started at 10pm 10/31 and still going strong  24 hrs later
Patient states she has rash on face, neck, and hands. She states that she has welps on her neck also.
0837 COVID VACCINE PFIZER GIVEN TO AN 8 YEAR OLD MALE WITH EXPIRED VACCINE. VACCINE EXPIRED 9/30/22.
Began Saturday PM/Sunday AM Mom noted beginning discoloration from waist to toes during routine check of child. Color deepened to dark red/blue splotches during the day. Two AM on 10/07/2001 was Med Center from 9pm -2:30am with IV's to keep veins open for Venus lab work. Complaining of stomach ache and vomited. Given Bactrium for blood in urine (?UTI). Tuesday  rash turning light brown. Note: saw MD in office Monday, took off Bactrium returned to Clinic two weeks.
flu like symptoms; bed for over 10 hours; This non-serious case was reported by a consumer via call center representative and described the occurrence of bedridden in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced bedridden (Verbatim: bed for over 10 hours) and flu like symptoms (Verbatim: flu like symptoms). The outcome of the bedridden was resolved (duration 10 hrs) and the outcome of the flu like symptoms was unknown.   It was unknown if the reporter considered the bedridden and flu like symptoms to be related to Shingrix.     It was unknown if the company considered the bedridden and flu like symptoms to be related to Shingrix.   Additional Information: GSK Receipt Date: 25-OCT-2023 The consumer called today reporting that he had his first dose of Shingrix recently and he had flu like symptoms and was in bed for over 10 hours. No further information was known. The reporter did not consent to follow up. The consumer declined to provide any demographic information, consent or physician information.
Had a friend stayed at home which present the exposure to COVID. Wednesday tested positive to COVID and he 02/22/2022. Urgent care for chest congestion, COVID and bronchitis and head cold. Z Pack antibiotic and quickly for 15 days Pre-existing. Dose 3 09/16/2021 FE3592. No fever some chills.
Pt received vaccines around 3:30pm. 10:30p-11:00p developed hives to face, arm, back and one at panty line no s/s reaction at inj site. ER advised BENADRYL PO at 11:00p (approx). Mom gave dose this am. Hives very itchy no s/s of swelling lips, mouth, tongue, throat. Pt felt bad after inj. had been playing outside earlier day. BENADRYL po q 6-8 hours x 48. ER with further problems. Mom to let us know 4-2-12 how she is.
Patient is a forty-four year-old female with a history of cervical cancer, who presents to the Emergency Department complaining of right shoulder pain beginning after 1st dose of COVID-19 vaccination in same arm on Friday. No fever. Symptoms have been constant. Worse with movement. Feel swelling into axilla.
After 2-3 days, skin itching with bumps along arms and around wrists and forearms.  By the end of that day, arms and stomach had bumps that opened up into sores (with clear fluid).  A day after the bumps ruptured, the right leg developed bumps, sores, and swelling.  Felt nausous the day the legs broke out, but never vomitted.  On 11-09-08, client went to immediate care and received a steroid shot.  Then went back on 11-13-08 and received another steroid shot and a steroid dose pack.  11-18-08: leg is still inflammed and new bumps that have ruptured (without pus).  Has since made an appointment with a dermatologist for further evaluation.
Patient was sweating profusely and dizzy. His blood pressure dropped to the 70's. After some hydration with Gatorade, patient got up and left on his own. He refused when offered to call for more help. After the vaccination, patient said he remembered he had the same reaction in the hospital when he received an anesthesia injection.